TABLE 2.

Findings for examining the association between stress measures and cognitive outcomes

		Main effect
Outcome measure	Stress measure	p-Value	β estimate	95% confidence interval
	Perceived Stress Scale
Trial duration (faces)	Low	Ref
	Medium	.96	−0.22	−8.6, 8.1
	High	.02	9.1	1.6, 16.6
Trial duration (shapes)	Low	Ref
	Medium	.02	8.4	1.6, 15.1
	High	.003	9.4	3.2, 15.7
Average run duration (faces)	Low	Ref
	Medium	.23	−0.53	−1.4, 0.33
	High	.04	−0.83	−1.6, −0.06
Average run duration (shapes)	Low	Ref
	Medium	.32	−0.39	−1.1, 0.40
	High	.19	−0.47	−1.2, 0.25
Novelty preferences (faces)	Low	Ref
	Medium	.96	−0.0007	−0.03, 0.03
	High	.6	0.007	−0.02, 0.03
Novelty preferences (shapes)	Low	Ref
	Medium	.58	−0.02	−0.07, 0.04
	High	.29	0.03	−0.02, 0.08
	Stressful Life Events
Trial duration (faces)	0	Ref
	1+	.11	5.6	−1.3, 12.5
Trial duration (shapes)	0	Ref
	1+	.24	4	−2.8, 10.8
Average run duration (faces)	0	Ref
	1+	.14	−0.51	−1.2, 0.17
Average run duration (shapes)	0	Ref
	1+	.08	−0.58	−1.2, 0.08
Novelty preferences (faces)	0	Ref
	1+	.85	−0.002	−0.02, 0.02
Novelty preferences (shapes)	0	Ref
	1+	.63	0.01	−0.04, 0.06
Trial duration (faces)		.04	−23.1	−45.3, −0.86
Trial duration (shapes)		.5	−7.66	−30.1, 14.8
Average run duration (faces)	Maternal telomere length	.23	1.46	−0.93, 3.8
Average run duration (shapes)		.56	0.65	−1.6, 1.9
Novelty preferences (faces)		.07	−0.07	−0.15, 0.01
Novelty preferences (shapes)		.15	−0.16	−0.38. 0.06

Note: Bold were those that reached significance p < .05 and italic were those p < .10. Main effect results are presented here, stratified models are presented in text and graphs.